North America Cold Plasma Market (2024-2029)
The North America Cold Plasma Market was valued at $912.2 Million in 2024 and projected to reach to $1499.9 Million by 2029, representing a compound annual growth rate of 10.5%. North America's cold plasma market is positioned for sustained expansion through 2029, driven by technological advancements and increasing clinical validation.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Cold Plasma Market Trends and Insights
- North America's advanced healthcare infrastructure and strong adoption of innovative medical technologies are driving this expansion.
- In North America, increasing investment in research and development, coupled with rising demand for minimally invasive surgical solutions, is accelerating market penetration across hospitals and outpatient surgical centers. North America's regulatory environment and favorable reimbursement policies are key enablers of cold plasma technology adoption.
- The region's leading medical device manufacturers and healthcare providers in North America are actively integrating cold plasma systems into clinical workflows.
- North America's competitive landscape features both established players and emerging innovators focused on expanding therapeutic applications and improving treatment efficacy..
Key Market Statistics
- CAGR (2024-2029) 10.5% CAGR
- Market Size, 2024 ~USD 912.2 Million
- Forecast, 2029 ~USD 1499.9 Million
- Geography North America
North America Cold Plasma Market Overview
Market Valuation & Growth :
North America's cold plasma market is valued at $912.2 million in 2024, with a robust CAGR of 10.5%, projected to reach $1,499.9 million by 2029, outpacing global growth expectations.
Advanced Healthcare Infrastructure :
North America benefits from world-class healthcare systems, significant R&D investments, and early adoption of cutting-edge medical technologies, positioning the region as a leader in cold plasma innovation.
Minimally Invasive Procedure Demand :
Rising demand for minimally invasive surgical and therapeutic procedures across North American healthcare facilities is driving cold plasma adoption in wound healing, sterilization, and dermatological applications.
Strong R&D Investment :
Increased funding in research and development by North American healthcare institutions and biotech companies is accelerating clinical applications and regulatory approvals for cold plasma technologies.
North America Cold Plasma Market Dynamics
- The region's mature healthcare ecosystem, coupled with strong reimbursement frameworks and regulatory support, creates favorable conditions for market penetration.
- Healthcare providers are increasingly adopting cold plasma solutions for their efficacy in reducing infection rates and improving patient outcomes. The forecast period will witness accelerated adoption across hospitals, surgical centers, and specialty clinics throughout the US and Canada.
- Continued investment in clinical research, combined with growing awareness among healthcare professionals and patients, will further propel market growth.
- Strategic partnerships between medical device manufacturers and healthcare institutions will enhance product accessibility and drive market expansion across North America..
Market Ecosystem
COLD PLASMA MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Enables controlled plasma processing for high-precision manufacturing, improving process uniformity and supporting advanced semiconductor and electronics production. | Develops plasma generators and plasma processing technologies used in semiconductor, electronics, and thin-film manufacturing applications, including etching, deposition, and surface treatment under controlled plasma conditions. |
 |
Enables precise, automated plasma treatment for surface modification, cleaning, and adhesion improvement, supporting consistent processing and reduced use of chemical pretreatment. | Provides plasma-based surface treatment solutions used for cleaning, activation, and surface modification of plastics, metals, glass, and electronic components | These systems help improve coating and adhesive bonding while supporting automated manufacturing processes. |
 |
Improves surface energy, adhesion, and wettability while enabling inline, chemical-free surface treatment with high process consistency. | Develops atmospheric-pressure plasma systems, including Openair-Plasma, for surface cleaning, activation, functionalization, and coating preparation across automotive, electronics, medical, and polymer industries. |
 |
Develops high-performance cleanroom garments, protective materials, and barrier fabrics used in pharmaceutical, semiconductor, and microelectronics facilities. | Provides atmospheric-pressure plasma systems for surface activation, cleaning, and functionalization of plastics, composites, metals, and other materials | Its plasma solutions can be integrated into automated production lines for continuous treatment. |
 |
Provides access to specialized plasma and scientific instrumentation technologies supporting advanced research, surface treatment, and industrial processing applications. | Through its scientific-instrumentation subsidiaries, supports specialized technologies used in research, materials analysis, plasma processing, and advanced industrial applications, depending on the subsidiary and product portfolio. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- North America's cold plasma market will grow from $912.2M (2024) to $1,499.9M (2029) at a 10.5% CAGR.
- North America's advanced healthcare infrastructure and regulatory framework support rapid technology adoption and clinical integration.
- North America's demand for minimally invasive surgical solutions is a primary driver of cold plasma market expansion.
- North America's competitive landscape includes both established medical device leaders and innovative startups developing next-generation cold plasma applications.
Cold Plasma Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MEDICAL INDUSTRY (Industry) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11% from 2024 to 2029 |
| Largest Segment | ATMOSPHERIC COLD PLASMA (Regime) |
| Market Size Base Year (Billions) | ~USD 2.14 (2024) |
| Revenue Forecast (Billions) | ~USD 3.6 (2029) |
| Segments Covered | Industry, Application, Regime |
North America Cold Plasma Market Report Segmentation
3 segment dimensions are covered across the global market.
By Industry
- Cosmetic Industry
- Electronics & Semiconductors Industry
- Food & Agriculture Industry
- Medical Industry
- Other Industries
- Polymer & Plastic Industry
- Textile Industry
By Application
- Aesthetic Procedures
- Coating & Thin-Film Deposition
- Other Applications
- Printing
- Surface Cleaning & Decontamination
- Surface Etching
- Surface Treatment & Activation
- Surgical
- Wound Healing
By Regime
- Atmospheric Cold Plasma
- Low-Pressure Cold Plasma
Target Audience
- Medical Device Manufacturers : Manufacturers need North America-specific market data to develop targeted product strategies, identify distribution channels, and optimize pricing for the US and Canadian markets.
- Healthcare Providers & Hospital Systems : Hospital administrators and procurement teams require market insights to evaluate cold plasma technology adoption, assess ROI, and make informed purchasing decisions for their facilities.
- Investment & Private Equity Firms : Investors need detailed North American market forecasts and growth metrics to identify promising cold plasma companies, assess market potential, and guide portfolio investment decisions.
- Regulatory & Compliance Consultants : Consultants require region-specific market intelligence to advise clients on North American regulatory pathways, reimbursement strategies, and market access for cold plasma products.
- Research Institutions & Biotech Companies : R&D organizations need market data to prioritize clinical research initiatives, identify funding opportunities, and align innovation efforts with North American healthcare demands.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 509.51 Million |
| Canada | USD 40.99 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($912.2M in 2024) with country-level breakdowns for the US and Canada, enabling accurate business planning and investment decisions.
- Growth Trajectory Analysis : Understand the 10.5% CAGR trajectory through 2029, identifying expansion opportunities and competitive positioning within North America's rapidly evolving cold plasma landscape.
- Healthcare Infrastructure Insights : Leverage detailed analysis of North America's advanced healthcare systems, regulatory environment, and reimbursement frameworks to optimize market entry and commercialization strategies.
- Application & End-User Segmentation : Access comprehensive data on cold plasma adoption across North American hospitals, surgical centers, and specialty clinics, identifying high-growth application areas and customer segments.
- Competitive & Strategic Intelligence : Gain actionable insights into North American market dynamics, key players, R&D trends, and partnership opportunities to inform strategic decision-making and resource allocation.
Frequently asked questions
What is the current size of the cold plasma market in North America?
The North America cold plasma market was valued at $912.2 million in 2024 and is expected to reach $1,499.9 million by 2029.
What is the projected growth rate for cold plasma in North America?
North America's cold plasma market is projected to grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2029.
What factors are driving cold plasma adoption in North America?
North America's growth is driven by advanced healthcare infrastructure, favorable reimbursement policies, increasing R&D investment, and rising demand for minimally invasive surgical solutions.
Which healthcare settings in North America are adopting cold plasma technology?
North America's hospitals and outpatient surgical centers are actively integrating cold plasma systems into their clinical workflows and treatment protocols.
Who are the key players in North America's cold plasma market?
North America's cold plasma market includes established medical device manufacturers and emerging innovators focused on expanding therapeutic applications and improving treatment outcomes.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the size of the cold plasma market. Exhaustive secondary research was conducted to gather information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Secondary Research
The secondary research process involved the extensive use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the cold plasma technologies market. It was also used to obtain important information about key players, market classification and segmentation according to industry trends down to the bottom level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from various companies and organizations operating in the cold plasma market. The primary sources on the demand side included industry experts, purchasing & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis
The research methodology used to estimate the size of the cold plasma market is as follows.
Market sizing was conducted from a global perspective.
Country-level Analysis: The size of the cold plasma market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall cold plasma market was obtained from secondary data and validated by primary participants to arrive at the total cold plasma market. Primary participants further validated the numbers.
Geographic Market Assessment (Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall cold plasma technologies market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Data Triangulation
After determining the overall size of the global cold plasma market using the aforementioned methodology, the market was segmented into several subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Plasma is the fourth state of matter. Cold plasma is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals and ground- and excited-state molecules. It is an innovative and convenient alternative to traditional technologies used across a wide range of industries, including textiles, electronics & semiconductors, polymers & plastics, medical, cosmetic and food & agriculture.
Key Stakeholders
- Cold plasma manufacturers and distributors
- Government and research organizations
- Cold plasma application industries
- Plasma technology component suppliers
- Medical device manufacturing companies
- Healthcare organizations
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
- Corporate entities
Report Objectives
- To describe, analyze, and forecast the cold plasma market by industry, application, regime, and region
- To describe and forecast the cold plasma market in key regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing market growth
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the cold plasma market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the cold plasma market
- To analyze the impact of AI/Gen AI on the cold plasma market in terms of its capabilities, potential, use cases, and future
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific cold plasma market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
- Further breakdown of the Rest of Europe cold plasma market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
- Further breakdown of the Rest of Latin America cold plasma market into Argentina, Peru, and other countries
- Further breakdown of Rest of Middle East & Africa cold plasma market into Israel, Iran, Iraq, Jordan, Yemen, and other countries.
Get the Full Cold Plasma Market Report
Full forecast, segment splits, and company analysis for all Cold Plasma Market.
- US Cold Plasma Market
- Canada Cold Plasma Market
- Germany Cold Plasma Market
- France Cold Plasma Market
- UK Cold Plasma Market
- Italy Cold Plasma Market
- Spain Cold Plasma Market
- China Cold Plasma Market
- Japan Cold Plasma Market
- India Cold Plasma Market
- South Korea Cold Plasma Market
- Australia Cold Plasma Market
- Brazil Cold Plasma Market
- Mexico Cold Plasma Market
- Rest Of Europe Cold Plasma Market
- Rest Of Asia Pacific Cold Plasma Market
- Rest Of Latin America Cold Plasma Market
- GCC Countries Cold Plasma Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
